Metformin Hydrochloride Eg (Eurogenerics) (Metformin Hydrochloride)

Metformin Hydrochloride is a biguanide antidiabetic agent used primarily in the management of type 2 diabetes mellitus.

• Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.
• Prediabetes (impaired fasting glucose): delays progression to overt diabetes.
• Gestational diabetes (when insulin is not required): assists in maintaining target glucose levels.

• Metformin Hydrochloride lowers blood glucose by inhibiting hepatic gluconeogenesis, decreasing intestinal glucose absorption, and enhancing peripheral insulin sensitivity through activation of AMP‑activated protein kinase (AMPK) pathways, which modulate glucose and lipid metabolism without directly stimulating insulin secretion.

Metformin Hydrochloride may cause a range of adverse reactions.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: frequent loose stools.
• Abdominal discomfort: cramping or pain.
• Metallic taste: transient alteration of taste perception.
• Loss of appetite: reduced desire to eat.
• Flatulence: increased intestinal gas.

Serious or Rare Side Effects

• Lactic acidosis: rare but life‑threatening metabolic disturbance.
• Severe skin reactions: such as Stevens‑Johnson syndrome.
• Hypoglycemia: when combined with other glucose‑lowering agents.
• Vitamin B12 deficiency: may develop with long‑term use.
• Hepatic dysfunction: abnormal liver enzymes.
• Acute pancreatitis: very rare inflammatory pancreas condition.

Metformin Hydrochloride requires careful consideration of several clinical factors before and during therapy.

• Renal function: assess eGFR before initiating and monitor periodically.
• Hepatic disease: use with caution in patients with liver impairment.
• Risk of lactic acidosis: avoid in conditions predisposing to hypoxia or severe infection.
• Alcohol consumption: limit intake to reduce acidosis risk.
• Pregnancy and lactation: evaluate risk‑benefit ratio with the prescriber.
• Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin Hydrochloride can interact with a variety of medicines, altering its efficacy or safety.

Major Interactions (Avoid)

• Iodinated contrast agents: increase risk of renal impairment and lactic acidosis.
• Cimetidine: may raise plasma metformin concentrations.
• Alcohol: potentiates lactic acidosis risk.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask hypoglycemia symptoms.
• ACE inhibitors or ARBs: monitor renal function and potassium levels.
• Thiazide diuretics: may attenuate glucose‑lowering effect.
• Digoxin: observe for altered drug levels.
• Warfarin: monitor INR as metformin may affect anticoagulation control.